Shots:

• The results of an interim analysis of P-III study showed that the safety of the new coronavirus inactivated vaccine after inoculation
• All patients produced high-titer Abs- the neutralizing Ab positive conversion rate was 99.52% while vaccine efficacy was 79.34%
• The vaccine has been granted authorization in several countries and has also been rolled out in part in China. The company is now seeking full approval in China

 ­ Ref: Sinopharm | Image: Sinopharm